AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Claziform 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Scott Edil Pharmacia Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Claziform 80mg/500mg Tablet SR

Diabexe 80mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe 80mg/500mg Extended-Release Tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and potential complications, including renal impairment, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most prevalent adverse reactions to Diabexe 80mg/500mg Extended-Release Tablets include hypoglycemia (low blood sugar), characterized by sweating, lightheadedness, headache, and tremors; constipation; and nausea. Knowing hypoglycemia symptoms and having readily available fast-acting glucose (e.g., sugary snacks or juice) is vital. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional side effects may encompass altered taste perception, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is a possibility. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Claziform 80mg/500mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Claziform 80mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Claziform 80mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Claziform 80mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.

Common Side effects of Claziform 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Claziform 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Claziform 80mg/500mg SR tablets should be taken with a meal.

How Claziform 80mg/500mg Tablet SR works:

Claziform SR tablets, containing 80mg of gliclazide and 500mg of metformin, offer dual antidiabetic action.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Claziform 80mg/500mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Prolonged-release Claziform 80mg/500mg tablets are contraindicated in pregnancy due to established fetal risk. Exceptions may exist in critical circumstances where the physician deems the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Claziform 80mg/500mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.

KidneyKidneyCAUTION

Patients with kidney impairment should use Claziform 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Claziform 80mg/500mg SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Claziform 80mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver dysfunction, initiate Claziform 80mg/500mg SR tablets at a reduced dosage; however, its administration is contraindicated in cases of severe liver disease.

What if you forget to take Claziform 80mg/500mg Tablet SR :

Should you forget to take a Claziform 80mg/500mg SR tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Claziform 80mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Claziform 80mg/500mg Tablet SR

Claziform 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Claziform is not suitable for type 1 diabetes.
Claziform 80mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claziform 80mg/500mg SR tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Claziform 80mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Claziform 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Claziform 80mg/500mg Tablet SR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Claziform 80mg/500mg SR Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Claziform 80mg/500mg SR tablets with alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Claziform 80mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Claziform is not suitable for type 1 diabetes.
Claziform 80mg/500mg SR Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Claziform 80mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Claziform 80mg/500mg Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Claziform 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Claziform 80mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Claziform 80mg/500mg SR Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Claziform 80mg/500mg SR tablets with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Claziform 80mg/500mg Tabl...
37
MRP 45
17% off